Author: Coronaheadsup.com
Significant long-term alterations in T cell populations in hospitalised Covid patients
“We see similar effects on patients with a chronic HIV infection with increased level of exhausted CD57+ CD8+ T cells.” More...
Research: “Omicron variant is highly likely a product of artificial genetic modification”
An extraordinary claim in a research paper just released: that the Omicron variant could be a product of artificial genetic modification. More...
BA.2.75.2: The “most immune evasive strain we have tested so far”
A Twitter post from Covid researcher Yunlong Cao claims that Omicron BA.2.75.2 is “currently the most immune evasive strain we have tested so far”. More...
Netherlands Covid-19: This must be some kind of mistake? *2 Updates*
It looks like a major error from whoever is inputting data into the Dutch Covid statistics feed, or perhaps at the OurWorldinData site. More...
UK: Fresh Covid-19 wave kicks off
The ZOE Covid app is showing that cases have started to climb in Britain again – just as schoolkids head back to school after the summer break. More...
WHO: Legionellosis outbreak in Tucuman, Argentina
“Further analyses of two bronchoalveolar lavage samples by highly sensitive total DNA sequencing found readings compatible with Legionella spp.”. More...
Zimbabwe: 700 child deaths from measles
The Zimbabwe Ministry of Health has released new figures for measles cases in the country. More...
Netherlands: Five scenarios for the future of the pandemic
The Netherlands has published a new guide to the future of the pandemic, laying out five possible scenarios for its evolution, including a worst-case scenario. More...
China: Covid-19 vaccine administered by inhaler approved
China has granted CanSinoBIO approval for its Recombinant COVID-19 Vaccine for Inhalation to be used as a booster dose. More...
Argentina: Two more deaths linked to pneumonia cluster in Tucuman + 8 NEW PATIENTS
The Argentinian authorities have announced two more patient deaths from the cluster of pneumonia cases that was announced last week. More...